Literature DB >> 4098046

Prevention or reversal of levodopa-induced cardiac arrhythmias by decarboxylase inhibitors.

L C Parks, A M Watanabe, I J Kopin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4098046     DOI: 10.1016/s0140-6736(70)92818-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Parkinsonism-physiology and pharmacology.

Authors:  D B Calne
Journal:  Br Med J       Date:  1971-09-18

2.  A dose rising study of the safety and effects on serum prolactin of SK&F 101468, a novel dopamine D2-receptor agonist.

Authors:  G Acton; C Broom
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

3.  The cardiovascular effects of bromocriptine in Parkinsonism.

Authors:  J K Greenacre; P F Teychenne; A Petrie; D B Calne; P N Leigh; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

Review 4.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 5.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.

Authors:  D B Calne; J L Reid; S D Vakil; S Rao; A Petrie; C A Pallis; J Gawler; P K Thomas; A Hilson
Journal:  Br Med J       Date:  1971-09-25

7.  Levodopa therapy of patients with Parkinsonism and heart disease.

Authors:  R B Jenkins; S H Mendelson; S Lamid; H L Klawans
Journal:  Br Med J       Date:  1972-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.